Ultimately the deal is in the range you talk about there. It's just that the up-front is so bulky & the associated milestones are only a bit more than the up-front - $425M = $190M up-front & $235M in future milestones.
Roche buys GeneWeave to boost antibiotics portfolio, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.015(1.18%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.25 | $36.69K | 29.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2500 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 450 | 2 |
View Market Depth
| Last trade - 10.00am 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |